Skip to main content

Mark Cuban

By Jessica Hagen | 11:34 am | October 29, 2024
Cuban told MobiHealthNews that he advocates for Harris because she announced she would take on non-pass-through PBMs and introduce drug transparency.
By Jessica Hagen | 02:41 pm | October 05, 2023
Avanlee Care will integrate MCCPDC's low-cost drug services into its Ava app to improve caregiver and care receiver resources.
By Jessica Hagen | 03:08 pm | September 06, 2023
The collaborators will improve access to Tiotropium Bromide Inhalation Powder in the U.S. for patients with COPD.
By Jessica Hagen | 06:40 pm | June 28, 2023
Posterity Health users will have access to medications through MCCPDC that help treat infertility, sexual dysfunction and low testosterone.
By Jessica Hagen | 08:18 pm | June 02, 2023
In a statement to MobiHealthNews, the cofounder of Mark Cuban Cost Plus Drug Company expressed excitement over the deal to offer the discounted Humira alternative.
By Jessica Hagen | 11:36 am | April 04, 2023
Zócalo Health users in Texas and California will have access to all medications available through Mark Cuban Cost Plus Drug Company in Zócalo's platform.
By Jessica Hagen | 11:16 am | February 21, 2023
Diathrive Health users will have access to Mark Cuban Cost Plus Drug Company's lower-cost diabetes medication and testing supplies.
By Jessica Hagen | 02:28 pm | January 31, 2023
OncoPower users will have access to Cost Plus Drugs' prescriptions through the partners' Medication Savings Suite.
By Jessica Hagen | 02:20 pm | December 08, 2022
The collaboration will offer low-cost medications to employees and employers through a new platform dubbed EmsanaRx Plus.
By Laura Lovett | 12:35 pm | January 21, 2022
The company recently rolled out a PBM operation, which it says will help it lower costs for its online pharmacy.